Skip to main content
Caplight Logo









BioCreate Program

BioCreate Program

Overview

BioCreate Program is an accelerator program providing seed funding and mentorship to small- and medium-sized enterprises in southern Ontario's health, food and agriculture, and cleantech sectors.

Year Founded

2023

Portfolio Companies

1

Investments

BioCreate Program investments
CompanyDateStageLead
Tessella BiosciencesMar 2026AcceleratorCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is BioCreate Program based?

BioCreate Program is headquartered in Canada.

When was BioCreate Program founded?

BioCreate Program was founded in 2023.

How many portfolio companies does BioCreate Program have?

BioCreate Program has 1 portfolio company in Caplight's dataset.

What are some companies in BioCreate Program's portfolio?

Portfolio companies visible on Caplight include Tessella Biosciences.

What was BioCreate Program's most recent investment shown here?

BioCreate Program's most recent investment in this portfolio sample was in Tessella Biosciences in 2026.

What sectors does BioCreate Program focus on?

BioCreate Program focuses on Healthcare & Life Sciences.

What company stages does BioCreate Program focus on?

BioCreate Program typically invests at the Early stage.

Firmographic Details

HeadquartersCanada
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?